• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
ZHANG Li,QU Hongliang,SUN Qiquan,YUAN Feifei,XUE Yunli.Quantitative analysis of genotoxic impurity 7, 8-didehydronaloxone in Oxycodone and Naloxone Hydrochloride Sustained-release Tablets by UHPLC-MS/MS[J].Journal Of Pharmaceutical Research,2025,44(1):32-35[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2805times   Download 1987次 QR Code for this article
Scan with your phone!
超高效液相色谱-串联质谱法定量分析羟考酮纳洛酮缓释片中基因毒性杂质7,8-二脱氢纳洛酮
张立,曲宏亮,孙启泉,苑菲菲,薛云丽
Font:Larger+|Default|Smaller-
(山东绿叶制药有限公司,山东 烟台 264003)
摘要:
目的 建立羟考酮纳洛酮缓释片中潜在基因毒性杂质7,8-二脱氢纳洛酮的超高效液相色谱-串联质谱(UHPLC-MS/MS)检测方法。方法 色谱柱为Waters Acquity CSH C18(2.1 mm×150 mm,1.7 μm),以0.77 g·L-1乙酸铵水溶液(冰醋酸调节pH为5.0)为流动相A,以乙腈为流动相B,梯度洗脱,流速为0.5 mL·min-1,柱温为50 ℃。采用多反应监测(MRM)模式,对羟考酮纳洛酮缓释片中的7,8-二脱氢纳洛酮进行定量检测。结果 7,8-二脱氢纳洛酮浓度在1.2~48 ng·mL-1范围内具有良好的线性关系。检测限和定量限分别为0.6 ng·mL-1和1.2 ng·mL-1。低、中、高3个浓度的加样回收率在93%~99%之间(n=9),RSD为2.4%。结论 该方法灵敏度高、专属性强,可用于羟考酮纳洛酮缓释片中7,8-二脱氢纳洛酮杂质的含量测定,为羟考酮纳洛酮缓释片杂质控制提供科学依据和定量分析方法。
关键词:  羟考酮纳洛酮缓释片  潜在基因毒性杂质  7,8二脱氢纳洛酮  超高效液相色谱-串联质谱  定量分析
DOI:10.13506/j.cnki.jpr.2025.01.006
基金项目:泰山产业领军人才工程资助项目;烟台市省级以上领军人才专项配套经费资助项目
Publication Date:January 25, 2025
Quantitative analysis of genotoxic impurity 7, 8-didehydronaloxone in Oxycodone and Naloxone Hydrochloride Sustained-release Tablets by UHPLC-MS/MS
ZHANG Li,QU Hongliang,SUN Qiquan,YUAN Feifei,XUE Yunli
(Shandong Luye Pharmaceutical Co., Ltd.,Yantai 264003, China)
Abstract:
Objective To establish an UHPLC-MS/MS method for determination of potential genotoxic impurity 7,8-didehydronaloxone in oxycodone and naloxone sustained-release tablets.Methods The separation was performed on Waters Acquity CSH C18 (2.1 mm×150 mm, 1.7 μm) column with the mobile phase consisting of 0.77 g·L-1 ammonium acetate aqueous solution (mobile phase A) and acetonitrile (mobile phase B) under a gradient elution at a flow rate of 0.5 mL·min-1 and a column temperature of 50 ℃. Multiple reaction monitoring (MRM) mode was used to quantitative detection of 7,8-didehydronaloxone in oxycodone and naloxone sustained-release tablets.Results The calibration curves was in good linearity for 7,8-didehydronaloxone in the range of 1.2-48 ng·mL-1. The LOD and LOQ were 0.6ng·mL-1 and 1.2ng·mL-1, respectively. The recoveries at low, middle, and high spiked concentrations was 93%-99% (n=9), and the RSD was 2.4%. Conclusion The method was sensitive and accurate, which can be applied for the quantifications of 7,8-didehydronaloxone in oxycodone and naloxone sustained-release tablets, providing scientific basis and quantitative analysis method for impurity control of oxycodone and naloxone sustained-release tablets.
Key words:  Oxycodone and naloxone sustained-release tablets  Potential genotoxic impurity  7,8-didehydronaloxone, UHPLC-MS/MS  Quantitative analysis method
Today's Visits:488    Total Visits:2383203
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.